OmniAb News

RBC Capital Remains a Buy on OmniAb (OABI)

TipRanksApr 8 21:46 ET

OmniAb Analyst Ratings

BenzingaMar 26 09:17 ET

Craig-Hallum Sticks to Their Buy Rating for OmniAb (OABI)

TipRanksMar 25 10:25 ET

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)

TipRanksMar 24 21:40 ET

OmniAb Analyst Ratings

BenzingaMar 22 13:30 ET

Benchmark Co. Reaffirms Their Buy Rating on OmniAb (OABI)

TipRanksMar 22 07:18 ET

OmniAb Analyst Ratings

BenzingaMar 21 11:08 ET

RBC Capital Reiterates Outperform on OmniAb, Maintains $7 Price Target

BenzingaMar 21 11:10 ET

OmniAb's Market Potential and Financial Stability Affirm Buy Rating

TipRanksMar 21 10:45 ET

Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI)

TipRanksMar 21 07:27 ET

Analysts Offer Insights on Healthcare Companies: Phreesia (PHR) and OmniAb (OABI)

TipRanksMar 21 07:10 ET

OmniAb's Strategic Growth and Resilience Reinforce Buy Rating Amidst Q4 Revenue Shortfall

TipRanksMar 20 20:55 ET

OmniAb (OABI) Receives a Buy From RBC Capital

TipRanksJan 26 20:47 ET

RBC Initiates OmniAb at Outperform With $6 Price Target, Says Stock Gives Exposure to Growth Potential of Monoclonal Antibody Therapies

MT NewswiresNov 29, 2023 07:42 ET

Benchmark Reiterates Buy on OmniAb, Maintains $8 Price Target

BenzingaNov 14, 2023 08:36 ET

OmniAb Analyst Ratings

BenzingaNov 14, 2023 08:35 ET

Benchmark Co. Reaffirms Their Buy Rating on OmniAb (OABI)

TipRanksNov 14, 2023 07:16 ET

OmniAb's Strong Q3 Results and Ongoing Innovation Bolster Buy Rating: An Analysis by Leerink Partners

TipRanksNov 14, 2023 01:55 ET

Analysts' Opinions Are Mixed on These Technology Stocks: Airgain (AIRG), OmniAb (OABI) and Par Technology (PAR)

TipRanksNov 10, 2023 12:10 ET

Craig-Hallum Sticks to Its Buy Rating for OmniAb (OABI)

TipRanksNov 10, 2023 10:50 ET